Bromocriptine

🧮 Dose calculator

Hyperprolactinaemia · Regimen source: FDA Bromocriptine · 2.3

• • Increase by up to 2.5 mg every 2–7 days as tolerated. FDA Bromocriptine · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Bromocriptine · 8.1

  “Postpartum Period: Avoid use of bromocriptine mesylate for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions [see Warnings and Precautions (5.4)] .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Bromocriptine · 8.2

  “Risk Summary Avoid the use of bromocriptine mesylate during lactation in postpartum females.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Bromocriptine · 8.4

  “The safety and effectiveness of bromocriptine mesylate have been established for the treatment of prolactin-secreting pituitary adenomas in pediatric patients 11 years of age and older.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Bromocriptine · 8.5

  “Clinical studies of bromocriptine mesylate did not include sufficient numbers of patients 65 years of age and older to determine whether they respond differently from younger adult patients.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Bromocriptine · 8.3

  “Contraception Females : Patients not seeking pregnancy, or those harboring large adenomas, should be advised to use appropriate contraceptive measures during treatment with bromocriptine mesylate.”